Michele Pizzuti
About
In The Last Decade
Michele Pizzuti
15 papers receiving 324 citations
Peers
Comparison fields: 5 of 58
- Hematology 140
- Pathology and Forensic Medicine 121
- Oncology 108
- Genetics 103
- Public Health, Environmental and Occupational Health 71
Countries citing papers authored by Michele Pizzuti
This map shows the geographic impact of Michele Pizzuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Pizzuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Pizzuti more than expected).
Fields of papers citing papers by Michele Pizzuti
This network shows the impact of papers produced by Michele Pizzuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Pizzuti. The network helps show where Michele Pizzuti may publish in the future.
Co-authorship network of co-authors of Michele Pizzuti
This figure shows the co-authorship network connecting the top 25 collaborators of Michele Pizzuti. A scholar is included among the top collaborators of Michele Pizzuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Pizzuti. Michele Pizzuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 24 | |
| 5 | 20 | |
| 6 | 4 | |
| 7 | 36 | |
| 8 | 44 | |
| 9 | Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi. | 25 |
| 10 | 5 | |
| 11 | 51 | |
| 12 | 52 | |
| 13 | Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin). | 12 |
| 14 | 51 | |
| 15 | Evaluation of LAK-mediated tumor cell killing in a plasma clot clonogenic assay. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.